Claire Hill is a bioprocess engineer at BioPharm Services UK, Lancer House, East Street, Chesham, Bucks, HP5 1DG, United Kingdom, +44
(0) 1494.793243, c.hill@biopharmservices.com
Andrew Sinclair is cofounder and managing director at BioPharm Services UK, Lancer House, East Street, Chesham, Bucks, HP5 1DG, United Kingdom,
+44 (0) 1494.793243, a.sinclair@biopharmservices.com
REFERENCES
1. Reichert JM. Trends in development and approval times for new therapeutics in the United States. Nature Reviews Drug Discovery.
2003;2(9):695–703.
2. Morris K, Venugopal S, Eckstut M. Making the most of drug development data. PharmaManufacturing 2005 Nov 30;4(10):16 –23.
3. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: New estimates of drug development costs. J Health Econ 2003;22(2):151–85.
4. American National Standards Institute/Instrumentation, Systems, and Automation Society (ANSI/ISA). ANSI/ISA-88.01–1995
Batch Control Part 1: Models and terminology. Research Triangle Park, NC; 1995.
5. American National Standards Institute/Instrumentation, Systems, and Automation Society (ANSI/ISA). ANSI/ISA-88.00.03–2003
Batch Control Part 3: General and site recipe models and representation. Research Triangle Park, NC; 2003.
|
